Thrombolysis Outcomes in Patients with Diabetes and Previous Stroke: A Meta-Analysis.
Azalea T PajoJose Danilo Bengzon DiestroRoland Dominic G JamoraAdam Andrew DmytriwAlejandro Enriquez-MarulandaRobert Joseph C SarmientoMarjorie Anne C BagnasJulian SpearsMaria Cristina Z San JosePublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2020)
Limited evidence suggests that thrombolysis in DM+/PCI+ patients does not result in significantly higher incidence of sICH and may improve functional independence. However, the significantly higher mortality in this group warrants an assessment of the individualized risk-benefit ratio in the use of IVtPA.
Keyphrases
- pulmonary embolism
- end stage renal disease
- atrial fibrillation
- risk factors
- newly diagnosed
- ejection fraction
- acute ischemic stroke
- coronary artery disease
- prognostic factors
- acute coronary syndrome
- acute myocardial infarction
- percutaneous coronary intervention
- type diabetes
- cardiovascular events
- st segment elevation myocardial infarction
- antiplatelet therapy
- adipose tissue
- coronary artery bypass grafting